Valproic acid management of acute alcohol withdrawal

Annals of Pharmacotherapy

Volumn 40, Issue 3, 2006, Pages 441-448

  Lum, Elaine ^a   Gorman, Sean K ^a,b   Slavik, Richard S ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Alcohol withdrawal; Ethanol; Valproic acid

Indexed keywords

ALCOHOL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CLOMETHIAZOLE; ELECTROLYTE; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; MULTIVITAMIN; OXAZEPAM; PHENOBARBITAL; PLACEBO; THIAMINE; TRANQUILIZER; VALPROATE SEMISODIUM; VALPROIC ACID;

ABSENCE OF SIDE EFFECTS; ALCOHOL WITHDRAWAL; ALCOHOLISM; CLINICAL FEATURE; CLINICAL TRIAL; DELIRIUM; DELIRIUM TREMENS; DETOXIFICATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; EPILEPTIC STATE; GASTROINTESTINAL SYMPTOM; HUMAN; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; VERTIGO; WITHDRAWAL SEIZURE;

ALCOHOL WITHDRAWAL DELIRIUM; ANTICONVULSANTS; BENZODIAZEPINES; HUMANS; RANDOMIZED CONTROLLED TRIALS; VALPROIC ACID;

EID: 33645049561     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G243     Document Type: Review

References (27)

1. US Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics, www.cdc. gov/nchs/fastats/alcohol.htm (accessed 2005 Jan 12).
2. Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA 1997; 278:144-51.
3. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Diagnosis and management of acute alcohol withdrawal. CMAJ 1999;160:675-80.
4. Reoux JP, Saxon AJ, Malte CA, Baer JS, Sloan KL. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. Alcohol Clin Exp Res 2001;25:1324-9.
5. Rosenthal RN, Ferkel C, Singh P, Anand O, Miner CR. A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal. Am J Addict 1998;7:189-97.
6. Johnson BA, Swift RM, Nassima A, DiClemente CC, Javors MA, Malcolm RJ. Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics. Alcohol Clin Exp Res 2004;28:295-301.
7. Hillbom M, Tokola R, Kuusela V, et al. Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Alcohol 1989;6:223-6.
8. Seifert J, Peters E, Jahn K, et al. Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance-a pilot study. Addict Biol 2004;9:43-51.
9. Lucht M, Kuehn KU, Armbruster J, et al. Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: a controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam. Alcohol Alcohol 2003;38:168-75.
10. Soyka M, Morhart-Klute V, Horak M. A combination of carbamazepine/ tiapride in outpatient alcohol detoxification. Results from an open clinical study. Eur Arch Psychiatry Clin Neurosci 2002;252:197-200.
11. Mueller TI, Stout RL, Rudden S, et al. A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcohol Clin Exp Res 1997;21:86-92.
12. Gallant DM. One more look at carbamazepine in the treatment of alcohol withdrawal. Alcohol Clin Exp Res 1992;16:1174-5.
13. Gallant DM. Improvements in treatment of alcohol withdrawal syndromes. Alcohol Clin Exp Res 1989;13:721-2.
14. Malcolm R, Ballenger JC, Sturgis ET, Anton R. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 1989;146:617-21.
15. Stojek A, Bilikiewicz A, Lerch A. Carbamazepine and physostigmine eyedrops in the treatment of early alcohol withdrawal and alcohol-related hypertension. Psychiatr Pol 1987;21:369-75.
16. Flygenring J, Hansen J, Holst B, Petersen E, Sorensen A. Treatment of alcohol withdrawal symptoms in hospitalized patients. A randomized, double-blind comparison of carbamazepine (Tegretol) and barbital (Diemal). Acta Psychiatr Scand 1984;69:398-408.
17. Agricola R, Mazzarino M, Urani R, Gallo V, Grossi E. Treatment of acute alcohol withdrawal syndrome with carbamazepine: a double-blind comparison with tiapride. J Int Med Res 1982;10:160-5.
18. Ritola E, Malinen L. A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 1981;64:254-9.
19. Roy-Byrne PP, Ward NG, Donnelly PJ. Valproate in anxiety and withdrawal syndromes. J Clin Psychiatry 1989;50(suppl):44-8.
20. Minuk GY, Rockman GE, German GB, Duerksen DR, Borrett G, Hoeschen L. The use of sodium valproate in the treatment of alcoholism. J Addict Dis 1995;14:67-74.
21. Brady KT, Myrick H, Henderson S, Coffey SF. The use of divalproex in alcohol relapse prevention: a pilot study. Drug Alcohol Depend 2002; 67:323-30.
22. Lambie DG, Johnson RH, Vijayasenan ME, Whiteside EA. Sodium valproate in the treatment of the alcohol withdrawal syndrome. Aust N Z J Psychiatry 1980;14:213-5.
23. Longo LP, Campbell T, Hubatch S. Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention. J Addict Dis 2002;21:55-64.
24. Myrick H, Brady KT, Malcolm R. Divalproex in the treatment of alcohol withdrawal. Am J Drug Alcohol Abuse 2000;26:155-60.
25. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
26. US Department of Health and Human Services. SAMHSA. The DASIS Report. Admissions of persons with co-occurring disorders: 2000. http://oas.samhsa.gov/ 2k3/dualTX/dualTX.htm (accessed 2005 Jan 21).
27. Williams D, Lewis J, McBride A. A comparison of rating scales for the alcohol-withdrawal syndrome. Alcohol Alcohol 2001;36:104-8.